-
Product Insights
Likelihood of Approval Analysis for Proliferative Diabetic Retinopathy (PDR)
Overview How likely is it that the drugs in Proliferative Diabetic Retinopathy (PDR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Proliferative Diabetic Retinopathy (PDR) Overview Proliferative diabetic retinopathy (PDR) is...
-
Product Insights
Likelihood of Approval Analysis for Diabetic Macular Edema
Overview How likely is it that the drugs in Diabetic Macular Edema will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Macular Edema Overview Diabetic macular edema (DME) occurs when blood...
-
Product Insights
Likelihood of Approval Analysis for Retinitis Pigmentosa (Retinitis)
Overview How likely is it that the drugs in Retinitis Pigmentosa (Retinitis) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinitis Pigmentosa (Retinitis) Overview Retinitis pigmentosa refers to a group of...
-
Product Insights
Likelihood of Approval Analysis for Macular Degeneration
Overview How likely is it that the drugs in Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Macular Degeneration Overview Macular degeneration is primarily an age-related retinal condition. There...
-
Product Insights
Likelihood of Approval Analysis for Uveitis
Overview How likely is it that the drugs in Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveitis Overview Uveitis is swelling and irritation of the uvea, the middle layer...
-
Product Insights
Likelihood of Approval Analysis for Retinal Vascular Occlusion
Overview How likely is it that the drugs in Retinal Vascular Occlusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinal Vascular Occlusion Overview Retinal vascular occlusion is a condition that...
-
Product Insights
Likelihood of Approval Analysis for Multiple Sclerosis
Overview How likely is it that the drugs in Multiple Sclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Multiple Sclerosis Overview Multiple sclerosis (MS) is an autoimmune disease in which...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...
-
Sector Analysis
NewIntraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intraocular Lens (IOL) Market Report Overview The intraocular lens (IOL) market was valued at $4.48 billion in 2023 and the market will grow at more than 2% during 2023-2033. The rising prevalence of cataracts and refractive error coupled with the increasing population around the globe has compelled governments to start initiatives toward lowering the number of patients suffering from partial or complete blindness. This, in turn, will lead to an increase in the number of eye surgeries and the use...
-
Thematic Analysis
NewPharma M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Pharma Sector